EXELIXIS, INC.

EXEL · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $11.1B · 1,077 employees
145
SEC Filings
$66.2
Close 2026-10-29
1,077
Employees

Business Summary

Exelixis, Inc. is a oncology-focused biopharmaceutical company that discovers, develops, and commercializes cancer treatments. The company's key marketed product is cabozantinib, sold under the brand names Cabometyx and Cometriq, approved for renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid cancer. Exelixis also has a pipeline of additional oncology compounds in clinical development.

Latest Stock Quote

EXEL 2026-10-29 $66.2 O:$66.93 H:$67.5199 L:$65.06 Vol:2.8M VWAP:$66.0007
origin leaf: null

Next Earnings

expected 2026-12-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-102026-01-020000939767-26-000021EDGAR46K words
2025-02-112025-01-030000939767-25-000019EDGAR88K words
2024-02-062023-12-290000939767-24-000028EDGAR88K words
2023-02-072022-12-300000939767-23-000019EDGAR92K words
2022-02-182021-12-310000939767-22-000026EDGAR93K words
2021-02-112021-01-010001628280-21-001852EDGAR93K words
2020-02-252020-01-030000939767-20-000035EDGAR88K words
2019-02-222018-12-280000939767-19-000042EDGAR93K words
2018-02-262017-12-290000939767-18-000023EDGAR89K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-10-292026-10-020000939767-26-000116EDGAR26K words
2026-08-052026-07-030000939767-26-000098EDGAR24K words
2025-11-042025-10-030000939767-25-000128EDGAR26K words
2025-07-282025-07-040000939767-25-000113EDGAR24K words
2025-05-132025-04-040000939767-25-000075EDGAR25K words
2024-10-292024-09-270000939767-24-000150EDGAR30K words
2024-08-062024-06-280000939767-24-000119EDGAR27K words
2024-04-302024-03-290000939767-24-000058EDGAR25K words
2023-11-012023-09-290000939767-23-000114EDGAR31K words
2023-08-012023-06-300000939767-23-000079EDGAR33K words
2023-05-092023-03-310000939767-23-000048EDGAR29K words
2022-11-012022-09-300000939767-22-000110EDGAR45K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-290000939767-26-000114EDGAR5K words
2026-09-110000939767-26-000108EDGAR0K words
2026-08-310000939767-26-000104EDGAR1K words
2026-08-050000939767-26-000096EDGAR5K words
2026-02-100000939767-26-000019EDGAR5K words
2026-01-120000939767-26-000003EDGAR4K words
2025-11-070000939767-25-000133EDGAR1K words
2025-11-040000939767-25-000127EDGAR5K words
2025-08-290000939767-25-000115EDGAR1K words
2025-07-280000939767-25-000111EDGAR5K words

145 total filings indexed. 114 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

oncology biopharmaceuticals

Company Identity

CIK0000939767
TickerEXEL
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.exelixis.com
Listed2000-04-11

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 9cd8d53ff82c76e26c5b20d322c9023a99a892c0edf8a5780b8bfc8060459ecf
parent: a287c7a708b419531c28768f8db35120751ea9b0cf589faf73fb50233063ec42
content hash: 6329fd5996ace6c8678775a5ec4bbad1c9c21691d92769773e397defbe48d6f5
signed: 2026-11-16T19:02:00.395Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up EXEL using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on EXEL, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/EXEL (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.